|
|
|
Insider
Information: |
Deschatelets Pascal |
Relationship: |
Chief Scientific Officer |
City: |
Crestwood |
State: |
KY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
1,115,983 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$46,101,258 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
1,115,983 |
|
|
Total
Value |
$46,101,258 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
5
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
5
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-5.0
|
Percentage
Gain/Loss : |
0.0%
|
-158.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Apellis Pharmaceuticals Inc |
APLS |
Chief Scientific Officer |
2024-05-08 |
1,115,983 |
2018-05-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
79 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
APLS |
Apellis Pharmaceuticals I... |
Chief Operating Officer |
|
2018-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
384,292 |
945,744 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Operating Officer |
|
2020-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
9,375 |
891,118 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Operating Officer |
|
2020-03-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
161,656 |
847,025 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2021-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
9,375 |
865,775 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2022-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
26,051 |
895,638 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2022-04-21 |
4 |
AS |
$0.00 |
$0 |
D/D |
(1,875) |
891,775 |
0 |
% |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2023-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
19,634 |
1,003,414 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2023-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
9,886 |
1,015,508 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,743 |
1,123,550 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2022-04-29 |
4 |
OE |
$2.67 |
$10,680 |
D/D |
4,000 |
895,775 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2021-04-28 |
4 |
OE |
$2.67 |
$12,015 |
D/D |
4,500 |
869,587 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2021-03-10 |
4 |
OE |
$2.67 |
$16,688 |
D/D |
6,250 |
871,337 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2021-04-23 |
4 |
OE |
$2.67 |
$16,688 |
D/D |
6,250 |
871,337 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2021-05-24 |
4 |
OE |
$2.67 |
$16,688 |
D/D |
6,250 |
875,837 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2021-06-24 |
4 |
OE |
$2.67 |
$16,688 |
D/D |
6,250 |
875,837 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2022-12-29 |
4 |
OE |
$3.67 |
$25,690 |
D/D |
7,000 |
977,280 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2021-02-10 |
4 |
D |
$47.72 |
$32,831 |
D/D |
(688) |
865,087 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2022-01-28 |
4 |
D |
$38.59 |
$35,927 |
D/D |
(931) |
894,707 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2023-01-27 |
4 |
D |
$52.77 |
$43,905 |
D/D |
(832) |
1,000,256 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2023-11-08 |
4 |
OE |
$2.67 |
$46,709 |
D/D |
17,494 |
1,083,807 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2022-07-08 |
4 |
OE |
$2.67 |
$49,395 |
D/D |
18,500 |
949,780 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2022-08-08 |
4 |
OE |
$2.67 |
$49,395 |
D/D |
18,500 |
956,280 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2022-09-08 |
4 |
OE |
$2.67 |
$49,395 |
D/D |
18,500 |
962,780 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2022-10-10 |
4 |
OE |
$2.67 |
$49,395 |
D/D |
18,500 |
969,280 |
0 |
- |
|
APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
|
2022-11-08 |
4 |
OE |
$2.67 |
$49,395 |
D/D |
18,500 |
975,780 |
0 |
- |
|
79 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|